Information solutions provider Thomson Scientific, part of Thomson Corporation, US, has announced the availability of its quarterly review of scientific literature on drugs and therapies, covering the period July - September 2007. The report, 'Who is Making the Biggest Splash?,' provides an objective assessment of how this volume of research is being received within the clinical community and to give expert measured insight into organisations that helped to shape professional opinions.
In this quarterly review, Thomson Scientific has assessed the quantity and quality of the materials published by pharmaceutical companies, research institutions and other non-commercial bodies in the last three months to identify which organisation has made the biggest splash. Thomson Scientific's findings report that Novartis maintained its top position for the second straight quarter. Researchers affiliated with the firm issued 96 abstracts or scientific posters between July and September 2007, an increase on the 82 articles identified in the previous quarter. The company continues to perform well, with a solid Thomson Source Score of 75. Although Eli Lilly and AstraZeneca swapped their second and third positions, this quarter's top five companies were all in the top five for the previous quarter.
Findings are based on information compiled by the Thomson Message Mapping System which provides data to the pharmaceutical industry in real-time. The service evaluates specific drugs and therapies against competitors as new studies are being published. The Thomson Message Mapping System applies proprietary algorithms to assess both the quantity and quality of scientific literature on drugs and therapies from the point of view of the practicing clinician. Through this, it helps pharmaceutical companies measure the overall impact of published scientific information.
A full copy of the report with analysis, is available at http://www.thomsonpharma.com/media/pdfs/tpqr/making-a-splash-sept2007.pdf
More News in this Theme
